Cargando…
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
BACKGROUND: Although melanoma brain metastases (MBM) tend to respond to systemic therapy concordantly with extracranial metastases, little is known about differences in immune cell and vascular content between the brain and other metastatic sites. Here we studied infiltrating immune cell subsets and...
Autores principales: | Weiss, Sarah A., Zito, Christopher, Tran, Thuy, Heishima, Kazuki, Neumeister, Veronique, McGuire, John, Adeniran, Adebowale, Kluger, Harriet, Jilaveanu, Lucia B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910371/ https://www.ncbi.nlm.nih.gov/pubmed/32974852 http://dx.doi.org/10.1007/s11060-020-03619-0 |
Ejemplares similares
-
19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA
por: Oria, Victor, et al.
Publicado: (2020) -
Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020) -
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma
por: Oria, Victor O., et al.
Publicado: (2022) -
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014) -
OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
por: Kennedy, Lucy Boyce, et al.
Publicado: (2021)